Reports
Sale
Global Transfection Technologies Market Size, Share, Price, Forecast: By Method: Reagent-based Method, Instrument-based Method, Other Methods; By Application: Biomedical Research, Therapeutic Delivery, Protein Production; By Products: Reagent, Instrument, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Transfection Technologies Market Outlook
The global transfection technologies market size was valued at USD 1,137.62 million in 2023, driven by the development of non-viral delivery systems across the globe. The market size is anticipated to grow at a CAGR of 8.50% during the forecast period of 2024-2032 to achieve a value of USD 2,370.64 million by 2032.
Transfection Technologies: Introduction
Transfection technologies are the techniques and methods that are used to introduce foreign genetic material into cells such as DNA and RNA. These technologies are widely used in gene therapies, drug discovery, and biotechnology. There are several merits and demerits of each transfection method available. Transfection can be achieved through viral or non-viral delivery systems. The most commonly used techniques are chemical transfection, electroporation, and viral-mediated transfection.
Transfection technologies are advancing in our understanding of genetics, facilitating drug discovery, and contributing to the development of innovative therapies. The continuous evolution and optimization of transfection methods contribute to the ongoing breakthroughs in molecular biology and can potentially participate in future advancements in fields such as gene therapy, regenerative medicine, and precision medicine.
Global Transfection Technologies Market Analysis
There are several key trends in the market including the development of non-viral delivery systems which are gaining popularity due to their improved safety profiles and ease of use compared to viral vectors. Additionally, gene editing technologies, cell-specific transfection, high throughput transfection, application specific transfection are also key trend contributing to the global transfection technologies market expansion.
Enhancing cell survival, decreasing, cytotoxicity, and, improving transfection efficiency are the main goals of ongoing research and development. The development of transfection methods that allow for the simultaneous transfection of numerous wells or cell arrays is a result of the necessity for high-throughput screening and analysis in drug discovery and functional genomics. Transfection procedures can be improved and standardized due to the growing integration of transfection technologies with laboratory automation systems, which is likely to aid the transfection technologies market growth. Automated transfection platforms allow accurate and reliable transfection across numerous samples, boosting throughput and reproducibility and accelerating market growth.
Global Transfection Technologies Market Segmentations
Market Breakup by Method
- Reagent-based Method
- Instrument-based Method
- Other Methods
Market Breakup by Application
- Biomedical Research
- Therapeutic Delivery
- Protein Production
Market Breakup by Products
- Reagent
- Instrument
- Others
Market Breakup by End User
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutes
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Transfection Technologies Market Overview
The market for transfection technologies has witnessed significant growth in recent years, and is expected to grow in coming years as well. The growth of the market is driven by the increasing demand for genetic research, drug discovery, and gene therapy applications. The market offers a range of transfection methods, including viral and non-viral delivery systems.
The transfection technologies market development is driven by the increasing focus on genetic research which includes functional genomics, proteomics, and personalized medicine. The increasing emphasis on genetic research, including genomics, proteomics, and personalized medicine is driving the demand for transfection technologies propelling the market growth. Recombinant proteins, monoclonal antibodies, and gene treatments are among the biopharmaceuticals that are in high demand. By facilitating the entry of recombinant DNA constructs into host cells for protein expression, transfection technologies play a crucial role in the manufacture of these complex biologics.
Transfection Technologies Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Lonza Group
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific
- Qiagen NV
- Promega Corporation
- SignaGen Laboratories
- Merck KGaA
- Altogen Biosystems
- Polyplus-transfection SA
- Mirus Bio
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Method |
|
| Breakup by Application |
|
| Breakup by Products |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Transfection Technologies Market Overview
3.1 Global Transfection Technologies Market Historical Value (2017-2023)
3.2 Global Transfection Technologies Market Forecast Value (2024-2032)
4 Global Transfection Technologies Market Landscape
4.1 Transfection Technologies: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Transfection Technologies: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Method
4.2.3 Analysis by Applications
5 Global Transfection Technologies Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Transfection Technologies Market Segmentation
6.1 Global Transfection Technologies Market by Method
6.1.1 Market Overview
6.1.2 Reagent-based Method
6.1.3 Instrument-based Method
6.1.4 Other Methods
6.2 Global Transfection Technologies Market by Application
6.2.1 Market Overview
6.2.2 Biomedical Research
6.2.3 Therapeutic Delivery
6.2.4 Protein Production
6.3 Global Transfection Technologies Market by Products
6.3.1 Market Overview
6.3.2 Reagent
6.3.3 Instrument
6.3.4 Others
6.4 Global Transfection Technologies Market by End User
6.4.1 Market Overview
6.4.2 Pharmaceutical and biotechnology companies
6.4.3 Contract research organizations
6.4.4 Academic and research institutes
6.5 Global Transfection Technologies Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Transfection Technologies Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Transfection Technologies Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Transfection Technologies Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Transfection Technologies Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Transfection Technologies Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Lonza Group
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Bio-Rad Laboratories, Inc.
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Thermo Fisher Scientific
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Qiagen NV
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Promega Corporation
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 SignaGen Laboratories
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Merck KGaA
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Altogen Biosystems
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Polyplus-transfection SA
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Mirus Bio
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 1,137.62 million in 2023, driven by the increasing genetic research.
The market is anticipated to grow at a CAGR of 8.50% during the forecast period of 2024-2032 and reach a market value of USD 2,370.64 million by 2032.
The increasing demand for genetic research is major drivers for the transfection technologies market.
The development of non-viral delivery systems, and technological advancement in the market are among the major key trends for the market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The products in the market include reagents, instruments among others.
The different methods in the market include reagent-based method, instrument-based method among other methods.
The different applications of transfection technologies include biomedical research, therapeutic delivery, protein production.
The end users of the transfection technologies include pharmaceutical and biotechnology companies, contract research organizations, academic and research institutes.
Key players involved in the market are Lonza Group, Bio-Rad Laboratories, Inc. Thermo Fisher Scientific, Qiagen NV, Promega Corporation, SignaGen Laboratories, Merck KGaA, Altogen Biosystems, Polyplus-transfection SA, and Mirus Bio.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER